Prophylactic therapy with omeprazole for prevention of equine gastric ulcer syndrome (EGUS) in horses in active training: A meta-analysis.
Abstract: Guidelines regarding the impact and value of prophylaxis or maintenance therapy in equine gastric ulcer syndrome (EGUS) are not well-established or defined. The merits and the magnitude of effects of prophylaxis for spontaneous or recurrent squamous gastric ulceration in horses in training are uncertain. Objective: To pool data from randomised controlled trials (RCTs) to eliminate reporting bias and evaluate the efficacy of prophylactic omeprazole in the prevention of EGUS in training horses, and secondarily to compare prophylactic dosages of omeprazole. Methods: Meta-analysis. Methods: This meta-analysis was conducted according to the recommendations of the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines. A systematic literature search identified RCTs comparing omeprazole prophylaxis with sham in prevention of EGUS. Data were analysed using the Mantel-Haenszel test method to calculate risk ratio (RR) or mean difference (MD) with 95% confidence intervals (CIs). Primary outcome was efficacy of prophylaxis. Secondary outcome was endoscopic severity of ulceration. The influence of study characteristics on the outcomes was examined by subgroup analyses. Results: In preventing gastric ulcer occurrence, omeprazole prophylaxis was superior to sham in training horses (7 trials, 566 horses, RR 0.28, 95% CI 0.18-0.43; 23.4% in omeprazole prophylaxis vs. 77.2% in sham; high quality evidence). Prevalence of ulceration was 75.3 and 87.2% in the sham arms of the 1 mg/kg and 2 mg/kg omeprazole groups, respectively. Severity scores were significantly lower for omeprazole vs. sham (mean difference [MD] -1.05; 95% CI -1.35 to -0.69). Subgroup analyses comparing prophylactic omeprazole dosages resulted in a mean difference of -0.94 and -1.60 for the 1 and 2 mg/kg groups, respectively. Conclusions: Studies showed heterogeneity with regard to prophylactic dose. Conclusions: Omeprazole prophylaxis in active training horses significantly reduces gastric ulceration compared with no prophylaxis (sham) with the absolute effect of 566 fewer ulcers per 1000 horses treated.
© 2018 EVJ Ltd.
Publication Date: 2018-05-17 PubMed ID: 29665126DOI: 10.1111/evj.12951Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
- Journal Article
- Meta-Analysis
- Systematic Review
Summary
This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.
This research article explores the use of preventative therapy with a drug called omeprazole for avoiding equine gastric ulcer syndrome (EGUS) in horses that are in active training. The study found that prophylactic use of omeprazole significantly decreased instances of gastric ulceration compared to no prevention methods.
Research Objective
The aim of the research was to gather data from randomized controlled trials (RCTs) to reduce reporting bias and assess the effectiveness of using omeprazole preventatively in training horses to avoid EGUS. A secondary objective was to compare the doses of omeprazole used prophylactically.
Methods
- The study is a meta-analysis, performed following the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines.
- The researchers identified relevant RCTs comparing omeprazole prevention to a sham in preventing EGUS through a systematic literature search.
- The Mantel-Haenszel test method was used to analyze the data and calculate risk ratios (RR) or mean differences (MD) along with 95% confidence intervals (Cis).
- The primary result was the effectiveness of preventative treatments while the secondary result was the endoscopic severity of the ulceration.
Results
- Preventative treatment with omeprazole was more successful than the sham in preventing gastric ulcers in training horses.
- The study involved seven trials with a total of 566 horses, leading to a risk ratio of 0.28 and 95% CI of 0.18-0.43.
- The prevalence of ulceration was 75.3% and 87.2% in the sham arms for the 1 mg/kg and 2 mg/kg omeprazole groups respectively.
- Severity scores were notably lower for the omeprazole group compared to the sham group, with a mean difference of -1.05 and 95% CI of -1.35 to -0.69.
Conclusion
- The research analysis showed diversity in relation to the prophylactic dosage.
- Using omeprazole as a preventative measure in actively training horses considerably minimizes gastric ulceration compared with no preventive measures, leading to an absolute effect of 566 fewer ulcers per 1000 horses treated.
Cite This Article
APA
Mason LV, Moroney JR, Mason RJ.
(2018).
Prophylactic therapy with omeprazole for prevention of equine gastric ulcer syndrome (EGUS) in horses in active training: A meta-analysis.
Equine Vet J, 51(1), 11-19.
https://doi.org/10.1111/evj.12951 Publication
Researcher Affiliations
- San Francisco State University, San Francisco, California, USA.
- Raritan Valley Community College, Branchburg, New Jersey, USA.
- Ethicon Inc., Somerville, New Jersey, USA.
MeSH Terms
- Animals
- Anti-Ulcer Agents / therapeutic use
- Bias
- Confidence Intervals
- Female
- Horse Diseases / epidemiology
- Horse Diseases / prevention & control
- Horses
- Male
- Odds Ratio
- Omeprazole / therapeutic use
- Physical Conditioning, Animal
- Prevalence
- Proton Pump Inhibitors / therapeutic use
- Risk Factors
- Stomach Ulcer / epidemiology
- Stomach Ulcer / prevention & control
- Stomach Ulcer / veterinary
- Syndrome
Citations
This article has been cited 6 times.- Klinck M, Lovett A, Sykes B. Incorporating a Behavioral Medicine Approach in the Multi-Modal Management of Chronic Equine Gastric Ulcer Syndrome (EGUS): A Clinical Commentary. Animals (Basel) 2025 Oct 17;15(20).
- Shan R, Steel CM, Sykes B. The Impact of Two Recommended Withholding Periods for Omeprazole and the Use of a Nutraceutical Supplement on Recurrence of Equine Gastric Ulcer Syndrome in Thoroughbred Racehorses. Animals (Basel) 2023 May 31;13(11).
- Vokes J, Lovett A, Sykes B. Equine Gastric Ulcer Syndrome: An Update on Current Knowledge. Animals (Basel) 2023 Apr 5;13(7).
- Hewetson M, Tallon R. Equine Squamous Gastric Disease: Prevalence, Impact and Management. Vet Med (Auckl) 2021;12:381-399.
- Sasaki N, Nishi Y, Fujiwara Y, Takeyama T, Kumagai H, Senarathna S, Ushiya S, Tokuyama T, Tokuyama T, Tokuyama T, Mii T, Ayaki S, Matsuno K, Nakagawa Y, Nishihara Y, Taura Y. Effect of a novel rice fermented extract on gastric ulcers in horses. J Equine Sci 2021 Jun;32(2):27-30.
- Padalino B, Davis GL, Raidal SL. Effects of transportation on gastric pH and gastric ulceration in mares. J Vet Intern Med 2020 Mar;34(2):922-932.
Use Nutrition Calculator
Check if your horse's diet meets their nutrition requirements with our easy-to-use tool Check your horse's diet with our easy-to-use tool
Talk to a Nutritionist
Discuss your horse's feeding plan with our experts over a free phone consultation Discuss your horse's diet over a phone consultation
Submit Diet Evaluation
Get a customized feeding plan for your horse formulated by our equine nutritionists Get a custom feeding plan formulated by our nutritionists